Literature DB >> 6753731

Complement activation in muscle fiber necrosis: demonstration of the membrane attack complex of complement in necrotic fibers.

A G Engel, G Biesecker.   

Abstract

The membranolytic C5b-9 complement membrane attach complex (MAC) is assembled after activation of either the classic or the alternative complement pathway. The quaternary configuration of the MAC macromolecule presents neoantigenic determinants not present on precursor molecules. Consequently, antibodies specific for these neoantigen(s) do not detect nonspecifically bound native complement precursors of MAC. By means of antibodies rendered specific for MAC neoantigen(s), MAC was localized by the immunoperoxidase reaction in cryostat sections of human muscle. In 66 biopsy specimens containing necrotic muscle fibers (Duchenne dystrophy, 13; other dystrophies, 15; inflammatory myopathies, 31; miscellaneous myopathies, 7) all of the necrotic fibers reacted for MAC neoantigen(s). C3 and C9 were also consistently localized in necrotic fibers, but localization of C1q, C4, and IgG was variable and often did not exceed background staining. None of the nonnecrotic fibers reacted for immunoglobulin or complement. Detection of MAC neoantigen(s) in necrotic fibers in a wide variety of muscle disease unambiguously shows that (1) the lytic complement pathway is consistently activated and participates in muscles fiber necrosis in vivo, and (2) complement reaction products are generated than can stimulate cellular infiltration and phagocytosis of the necrotic fiber. The findings also suggest that cell necrosis in general may involve participation of complement.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6753731     DOI: 10.1002/ana.410120314

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  29 in total

1.  A morphometric technique for the histological quantification of skeletal muscle regeneration.

Authors:  S A Marlow; J K McGeachie; M Tennant; J M Papadimitriou
Journal:  J Anat       Date:  1996-08       Impact factor: 2.610

Review 2.  Functions and relevance of the terminal complement sequence.

Authors:  S Bhakdi; F Hugo; J Tranum-Jensen
Journal:  Blut       Date:  1990-06

3.  Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers.

Authors:  Fedik Rahimov; Oliver D King; Doris G Leung; Genila M Bibat; Charles P Emerson; Louis M Kunkel; Kathryn R Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

4.  Anti-dystrophin T cell responses in Duchenne muscular dystrophy: prevalence and a glucocorticoid treatment effect.

Authors:  Kevin M Flanigan; Katie Campbell; Laurence Viollet; Wei Wang; Ana Maria Gomez; Christopher M Walker; Jerry R Mendell
Journal:  Hum Gene Ther       Date:  2013-09       Impact factor: 5.695

5.  Immune myopathy with large histiocyte-related myofiber necrosis.

Authors:  Alan Pestronk; Namita Sinha; Ziad Alhumayyd; Cindy Ly; Robert Schmidt; Robert Bucelli
Journal:  Neurology       Date:  2019-03-20       Impact factor: 9.910

Review 6.  Immunological features of polymyositis/dermatomyositis.

Authors:  W M Behan; P O Behan
Journal:  Springer Semin Immunopathol       Date:  1985

7.  Sarcolemmal Complement Membrane Attack Complex Deposits During Acute Rejection of Myofibers in Nonhuman Primates.

Authors:  Daniel Skuk; Jacques P Tremblay
Journal:  J Neuropathol Exp Neurol       Date:  2019-01-01       Impact factor: 3.685

8.  High prevalence of acute myocardial damage in a hospital necropsy series, shown by C9 immunohistology.

Authors:  M A Ferreira; H E Owen; A J Howie
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

9.  Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries.

Authors:  F Niculescu; F Hugo; H G Rus; R Vlaicu; S Bhakdi
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

10.  Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.

Authors:  C L Koski; M E Sanders; P T Swoveland; T J Lawley; M L Shin; M M Frank; K A Joiner
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.